FBB
MDT icon

Fulton Breakefield Broenniman’s Medtronic MDT Stock Holding History

Fulton Breakefield Broenniman’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,472
Closed -$270K – 175
2022
Q4 		$270K Buy
+3,472
New +$281K 0.02% 152

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fulton Breakefield Broenniman's MDT Position: Q1 2023 in Review

Fulton Breakefield Broenniman sold out of Medtronic (MDT) in Q1 2023, closing a stake of 3,472 shares — an estimated $270K sold.

Fulton Breakefield Broenniman first reported a position in MDT in Q4 2022 and held it in 1 quarter. The position peaked at $270K in Q4 2022. 1,990 funds tracked by Wall St. Rank hold MDT as of Q1 2023.

  • Fulton Breakefield Broenniman reported no remaining Medtronic position as of Q1 2023 after selling out during the quarter.
  • Fulton Breakefield Broenniman sold 3,472 Medtronic shares in Q1 2023, an estimated $270K.
  • Fulton Breakefield Broenniman first reported a position in Medtronic in Q4 2022 and held it in 1 quarter.
  • Fulton Breakefield Broenniman's Medtronic position peaked at $270K in Q4 2022.
  • 1,990 funds tracked by Wall St. Rank held Medtronic as of Q1 2023.

Based on Fulton Breakefield Broenniman's 13F filing for Q1 2023, filed 25 Apr 2023.